SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,217.45 -255.49
( -0.33%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,269.23 412.80
(0.63%)

Nikkei 225

10,888.36 2.20
(0.02%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

79.89

239321.25

EPS(TTM)

Face Value()

Div & Yield %

112.85

0.33

Back

Oasis Securities standalone net profit declines 28.79% in the June 2026 quarter

Aug 07,2026

Net profit of Oasis Securities declined 28.79% to Rs 0.47 crore in the quarter ended June 2026 as against Rs 0.66 crore during the previous quarter ended June 2025. Sales rose 25.29% to Rs 1.09 crore in the quarter ended June 2026 as against Rs 0.87 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.09	0.87	25
OPM %	57.80	88.51	-
PBDT	0.63	0.77	-18
PBT	0.63	0.77	-18
NP	0.47	0.66	-29

77,217.45 -255.49 ( -0.33%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,269.23 412.80 (0.63%)

10,888.36 2.20 (0.02%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)